Novartis Manufacturing NV
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- Belgium
- Registered address
- Rijksweg 14, Puurs-Sint-Amands, 2870, Belgium (BEL)
- Operations here
- labelmanufacturepack
- FDA identifiers
- FEI 3002037047 · DUNS 370205429
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2025-03-05
- VAIDrug Quality Assurance2021-04-29
- VAIDrug Quality Assurance2018-11-09
- VAIDrug Quality Assurance2016-11-15
- NAIDrug Quality Assurance2014-03-26
- NAIDrug Quality Assurance2010-01-29
Drugs this plant is listed as making
3 distinct drugs across 3 products name this site in their FDA label.
- balanced salt solutionAlcon Laboratories, Inc.
- brinzolamide/brimonidine tartrateAlcon Laboratories, Inc.
- neomycin sulfate, polymyxin b sulfate and dexamethasoneNordic Pharma, Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.